Gilead Sciences, Inc. (LON: 0QYQ)

Gilead Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 29, 2024	Dec 30, 2023	Dec 30, 2022	Dec 30, 2021	Dec 30, 2020	Dec 30, 2019
Cash & Equivalents	5,037	6,085	5,412	5,338	5,997	11,631
Short-Term Investments	1,660	2,265	1,446	2,067	2,827	13,040
Cash & Short-Term Investments	6,697	8,350	6,858	7,405	8,824	24,671
Cash Growth	-16.01%	21.76%	-7.39%	-16.08%	-64.23%	-20.29%
Accounts Receivable	4,587	4,660	4,777	4,493	4,892	3,582
Other Receivables	-	-	-	-	-	37
Receivables	4,587	4,660	4,777	4,493	4,892	3,619
Inventory	1,869	1,787	1,507	1,618	1,683	922
Prepaid Expenses	1,620	1,281	1,241	1,181	585	1,047
Other Current Assets	6	7	60	75	12	37
Total Current Assets	14,779	16,085	14,443	14,772	15,996	30,296
Property, Plant & Equipment	5,391	5,898	5,980	5,663	5,613	5,170
Long-Term Investments	730	2,159	2,611	2,844	3,820	5,139
Goodwill	8,314	8,314	8,314	8,332	8,108	4,117
Other Intangible Assets	20,546	26,454	28,894	33,455	33,126	13,786
Other Long-Term Assets	4,765	3,215	2,929	2,886	1,744	3,119
Total Assets	54,525	62,125	63,171	67,952	68,407	61,627
Accounts Payable	903	550	905	705	844	713
Accrued Expenses	5,164	5,003	4,497	6,996	6,390	6,018
Current Portion of Long-Term Debt	1,812	1,798	2,273	1,516	2,757	2,499
Current Portion of Leases	-	125	111	101	107	99
Current Income Taxes Payable	1,536	1,208	959	539	598	287
Other Current Liabilities	2,310	2,596	2,492	1,753	701	143
Total Current Liabilities	11,725	11,280	11,237	11,610	11,397	9,759
Long-Term Debt	21,437	23,189	22,957	25,179	28,645	22,094
Long-Term Leases	-	546	467	489	608	626
Long-Term Deferred Tax Liabilities	794	1,588	2,673	4,356	3,914	-
Other Long-Term Liabilities	2,178	2,773	4,628	5,254	5,622	6,498
Total Liabilities	36,134	39,376	41,962	46,888	50,186	38,977
Common Stock	1	1	1	1	1	1
Additional Paid-In Capital	7,327	6,500	5,550	4,661	3,880	3,051
Retained Earnings	11,073	16,304	15,687	16,324	14,381	19,388
Comprehensive Income & Other	74	28	2	83	-60	85
Total Common Equity	18,475	22,833	21,240	21,069	18,202	22,525
Minority Interest	-84	-84	-31	-5	19	125
Shareholders' Equity	18,391	22,749	21,209	21,064	18,221	22,650
Total Liabilities & Equity	54,525	62,125	63,171	67,952	68,407	61,627
Total Debt	23,249	25,658	25,808	27,285	32,117	25,318
Net Cash (Debt)	-16,552	-16,145	-17,705	-18,571	-22,791	841
Net Cash Growth	-	-	-	-	-	-83.36%
Net Cash Per Share	-13.25	-12.83	-14.03	-14.72	-18.05	0.66
Filing Date Shares Outstanding	1,246	1,246	1,247	1,254	1,257	1,264
Total Common Shares Outstanding	1,246	1,246	1,247	1,254	1,254	1,266
Working Capital	3,054	4,805	3,206	3,162	4,599	20,537
Book Value Per Share	14.83	18.33	17.03	16.80	14.52	17.79
Tangible Book Value	-10,385	-11,935	-15,968	-20,718	-23,032	4,622
Tangible Book Value Per Share	-8.33	-9.58	-12.81	-16.52	-18.37	3.65
Land	-	561	562	404	404	404
Buildings	-	4,328	4,390	3,794	3,678	3,358
Machinery	-	2,216	1,990	1,759	1,697	1,439
Construction In Progress	-	661	719	1,057	856	723

Source: S&P Capital IQ. Standard template. Financial Sources.